Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M843Revenue $M20.9Net Margin (%)-248.5Z-Score13.0
Enterprise Value $M712EPS $-0.3Operating Margin %-250.7F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-248.4Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %-2.0Quick Ratio3.9Cash flow > EarningsY
Price/Sales33.65-y EBITDA Growth Rate %-12.9Current Ratio4.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-22.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)7ROE % (ttm)-25.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M153ROI % (ttm)-57.0Gross Margin Increase y-yY

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
$ 4.0315%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
$ 4.0343%New holding, 573000 sh.573,000
NVAXJean-Marie Eveillard 2013-09-30 Buy 0.01%$2.25 - $3.39
$ 4.0343%New holding, 800000 sh.800,000
NVAXJean-Marie Eveillard 2011-03-31 Sold Out $2.15 - $2.96
$ 4.0365%Sold Out0
NVAXJean-Marie Eveillard 2010-09-30 Add$2.01 - $2.34
$ 4.0383%Add 25%125,000
NVAXJean-Marie Eveillard 2010-06-30 Reduce$2.18 - $2.97
$ 4.0364%Reduce -52.65%100,000
NVAXJean-Marie Eveillard 2009-12-31 Buy 0.01%$2.53 - $4.41
$ 4.0316%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVAX Jean-Marie Eveillard 2013-12-31800,0000.520.01
NVAX George Soros 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!

NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DOUGLAS RICHARDDirector 2014-03-25Buy50,000$4.33-6.93view
Erck Stanley CCEO and President 2014-03-25Buy10,000$4.27-5.62view
PHILLIPS BARCLAY ASVP, CFO 2014-03-25Buy5,000$4.25-5.18view
YOUNG JAMES FDirector 2014-03-25Buy25,000$4.47-9.84view
Cadila Pharmaceuticals Ltd10% Owner 2014-03-21Sell3,000,000$4.95-18.59view
Modi Rajiv I.Director 2014-03-21Sell3,000,000$4.95-18.59view
Glenn Gregory MSVP, Research and Development 2014-03-14Sell29,000$5.48-26.46view
Glenn Gregory MSVP, Research and Development 2014-01-31Buy4,102$2.2975.98view
PHILLIPS BARCLAY ASVP, CFO 2014-01-31Buy9,868$2.2975.98view
Hahn Timothy JonSVP, Manufacturing & PD 2014-01-31Buy9,416$2.2975.98view

Press Releases about NVAX :

    Quarterly/Annual Reports about NVAX:

    News about NVAX:

    Articles On GuruFocus.com
    comment on NVAX Mar 16 2013 
    comment on NVAX Mar 16 2013 
    Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
    creiter note on NVAX Jan 03 2010 
    Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
    Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
    Novavax Reports Second Quarter 2009 Financial Results Aug 07 2009 
    Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial